Las Vegas, NV -- (SBWIRE) -- 12/24/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Cell Therapeutics Inc (NASDAQ:CTIC),Aruba Networks, Inc. (NASDAQ:ARUN).Broadcom Corporation (NASDAQ:BRCM).Alimera Sciences Inc (NASDAQ:ALIM)
Cell Therapeutics Inc (NASDAQ:CTIC) managed to keep its gain at 1.13% on below normal volume of 1.07M shares. The stock settled at $1.79 after floating in a range of $1.75 to $1.80. Its latest price has reached market capitalization of $232.42 million. Its 52-week range has been $0.97 to $2.17. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need.
For How Long CTIC will fight for Profitability? Read This Trend Analysis report
Aruba Networks, Inc. (NASDAQ:ARUN) traded down on a volume of 2.37 million, lower than its standard daily volume. Shares have dropped-1.58% to $17.46. Over the last twelve months, the stock has gained 1.1% and faced a worst price of $12.38. Aruba Networks, Inc., is a provider of next-generation network access solutions for mobile enterprise networks.
Has ARUN Found The Bottom And Ready To Gain Momentum? Find Out Here
Broadcom Corporation (NASDAQ:BRCM) settled 1.61% higher at $29.03 on below normal volume of 7.91M shares during the last trading day. The stock has its 12-month high at $37.85 and 52-week low price was $23.25. It traded in a range of $28.73 to $29.25 during the last trading day. Broadcom Corporation (Broadcom) is a global semiconductor solution for wired and wireless communications. Broadcom products seamlessly deliver voice, video, data and multimedia connectivity in the home, office and mobile environment. The Company provides system-on-a-chip (SoC), and software solutions.
Why Should Investors Buy BRCM After the Recent Fall? Just Go Here and Find Out
In the last trading session, Alimera Sciences Inc (NASDAQ:ALIM) was up on high volume, trading at a volume of 1.06M shares versus its average daily volume of 261,549.00 shares. At $4.56, the stock has attained market capitalization of $144.15million. Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases.
Will ALIM Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)